Safety of PATANASE Nasal Spray in Patients With Perennial Allergic Rhinitis

Inclusion Criteria:

1. Sign informed consent;

2. Normal nasal exam;

3. History of perennial allergic rhinitis;

4. Allergy to perennial allergen documented by allergy testing;

5. Age 12 years and older;

6. Must follow instructions;

7. Must make required study visits;

8. Negative pregnancy test and adequate birth control methods for females of childbearing
potential;

9. Refrain from certain allergy medications during the study;

10. Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

1. Nasal disorders;

2. Use of substances that affect the nasal septum;

3. Exposure to industrial metal plating solutions;

4. Uncontrolled, severe, or unstable diseases;

5. Hypersensitivity to the study drug or nasal spray components;

6. Relative of site staff with access to the protocol;

7. Participation in another investigational study within 30 days or at the same time as
this study;

8. Medical Monitor decision;

9. Other protocol-defined exclusion criteria may apply.